CV Lattes
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Coordenadoria de Serviços de Saúde (CSS). Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira (ICESP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Ciências Biológicas from Universidade de São Paulo (1999), master's at Physiology from Universidade de São Paulo (2003) and doctorate at Oncologia from Faculdade de Medicina da USP (2007). Has experience in Morphology, focusing on Cytology and Celular Biology, acting on the following subjects: melanoma, melatonina, melatonin, proteína g and pkc. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Malignant tumors can be defined as microenvironments composed by different cell types that interact with each other, dictating the natural history of the disease and the response to treatment. This cellular interaction is mediated not only by soluble factors, but also by extracellular vesicles (EVs). EVs are spherical nanostructures, secreted by many cell types, which play an important ro…
Cancer is considered a worldwide health problem and causes many deaths, despite the advances in medicine, the rate is still growing. Furthermore, despite the introduction of targeted-therapies, there is still a high rate of non-response to treatment and relapses. Melanoma skin cancer, despite not being one of the most incidents, is characterized by its high malignancy and rapid progressio…
Melanoma is considered the most aggressive form of skin cancer. Although recently approved treatments, including immunotherapy with immune checkpoint blockage, resulted in improved patient prognosis, resistance mechanisms still represent major obstacles. Immune infiltration profile within the tumor microenvironment is among the factors influencing tumor response, and a highly immunosuppre…
Melanoma poses a significant challenge due to its aggressive nature and resistance to standard-of-care approaches. RNA-based drugs, targeting multiple key pathways, have been investigated as an alternative to bypass these resistant phenotypes and enhance treatment efficacy. Despite the recent advances, RNA chemical instability, rapid clearance, and lack of specific tumor targeting still r…
| 3 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 3 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 8 / 6 | All research grants and scholarships |
| Associated processes | |